| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| Achillion Pharmaceuticals Inc | NASDAQ | ACHN | 7.79 | 47.6% | 83.3% | 8.49 | 2.26 | 73,497,868 | 754.0 |
| Doral Financial Corp | NYSE | DRL | 4.94 | 17.3% | 21.4% | 25 | 1.87 | 2,598,797 | 32.8 |
Achillion Pharmaceuticals Inc (NASDAQ: ACHN), a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases, gained more than 170% during its past two trading sessions gaining more than 47% in each of the two consecutive days. During its last trading session, the stock jumped 83% closing at $7.79 with significant trading volumes of 73 million shares. During its past 5-trading sessions, ACHN surged 190% with 5-day average volume of 25 million shares compared to 1-month daily average volume of 5 million shares.
Doral Financial Corp (NYSE: DRL), a bank holding company engaged in retail banking activities in Puerto Rico and the U.S. through its banking subsidiary, gained more than 42% during its past two trading sessions gaining more than 17% in each of the two consecutive days. During its last trading session, the stock jumped 21% closing at $4.94 with significant trading volumes of 2.6 million shares. During its past 5-trading sessions, DRL surged 67% with 5-day average volume of 1.2 million shares compared to 1-month daily average volume of 1.8 million shares.
